Puma Biotechnology, Inc. (PBYI)
9.97
+0.16
(+1.63%)
USD |
NASDAQ |
Oct 08, 16:00
10.09
+0.12
(+1.20%)
Pre-Market: 20:00
Puma Biotechnology Total Return Level : 9.97 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 9.97 |
| October 07, 2026 | 9.81 |
| October 06, 2026 | 9.50 |
| October 05, 2026 | 9.67 |
| October 02, 2026 | 9.51 |
| October 01, 2026 | 9.84 |
| September 30, 2026 | 9.93 |
| September 29, 2026 | 9.78 |
| September 28, 2026 | 9.82 |
| September 25, 2026 | 9.77 |
| September 24, 2026 | 9.82 |
| September 23, 2026 | 9.28 |
| September 22, 2026 | 9.82 |
| September 21, 2026 | 9.59 |
| September 18, 2026 | 9.60 |
| September 17, 2026 | 9.52 |
| September 16, 2026 | 9.39 |
| September 15, 2026 | 9.25 |
| September 14, 2026 | 9.14 |
| September 11, 2026 | 9.12 |
| September 10, 2026 | 9.17 |
| September 09, 2026 | 9.05 |
| September 08, 2026 | 9.39 |
| September 04, 2026 | 9.55 |
| September 03, 2026 | 9.41 |
| Date | Value |
|---|---|
| September 02, 2026 | 9.69 |
| September 01, 2026 | 9.35 |
| August 31, 2026 | 9.11 |
| August 28, 2026 | 9.06 |
| August 27, 2026 | 9.24 |
| August 26, 2026 | 9.16 |
| August 25, 2026 | 9.32 |
| August 24, 2026 | 9.12 |
| August 21, 2026 | 9.24 |
| August 20, 2026 | 9.11 |
| August 19, 2026 | 9.49 |
| August 18, 2026 | 9.24 |
| August 17, 2026 | 8.82 |
| August 14, 2026 | 8.83 |
| August 13, 2026 | 8.71 |
| August 12, 2026 | 8.90 |
| August 11, 2026 | 8.77 |
| August 10, 2026 | 8.69 |
| August 07, 2026 | 8.91 |
| August 06, 2026 | 8.12 |
| August 05, 2026 | 7.99 |
| August 04, 2026 | 7.80 |
| August 03, 2026 | 7.69 |
| July 31, 2026 | 7.93 |
| July 30, 2026 | 7.89 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Arcutis Biotherapeutics, Inc. | 24.49 |
| ACADIA Pharmaceuticals, Inc. | 19.58 |
| Alnylam Pharmaceuticals, Inc. | 224.53 |
| Savara, Inc. | 4.83 |
| Vericel Corp. | 40.05 |